Patients with diabetes mellitus have an increased prevalence of hypertension and its vascular consequences, including coronary and cerebrovascular disease. Drug treatment of hypertension in diabetic subjects is fraught with potential difficulties, including the altered efficacy of medications, the increased risk of side effects, and the possibility of worsening glycemic control and increasing serum lipid levels. Despite these difficulties, treatment is an important part of reducing morbidity and mortality from vascular events. Antihypertensive therapy may also have the potential to prevent or retard the development of diabetic nephropathy. In this article, we discuss the efficacy and metabolic and nonmetabolic side effects of the various classes of antihypertensive agents in patients with diabetes mellitus and suggest a stepped-care approach to the drug treatment of patients with hypertension and diabetes.
Skip Nav Destination
Article navigation
Original Articles|
June 01 1991
Drug Treatment of Hypertension in Patients With Diabetes Mellitus
Peter P Stein, MD;
Peter P Stein, MD
The Section of Endocrinology and Cardiovasclar Medicine, Yale University School of Medicine
New Haven, Connecticut
Search for other works by this author on:
Henry R Black, MD
Henry R Black, MD
The Section of Endocrinology and Cardiovasclar Medicine, Yale University School of Medicine
New Haven, Connecticut
Search for other works by this author on:
Address correspondence and reprint requests to Henry R. Black, MD, Section of Cardiovascular Medicine, 333 Cedar Street, New Haven, CT 06510
Citation
Peter P Stein, Henry R Black; Drug Treatment of Hypertension in Patients With Diabetes Mellitus. Diabetes Care 1 June 1991; 14 (6): 425–448. https://doi.org/10.2337/diacare.14.6.425
Download citation file: